Oncostatin M receptor β deficiency attenuates atherogenesis by inhibiting JAK2/STAT3 signaling in macrophages

Oncostatin M receptor β deficiency attenuates atherogenesis by inhibiting JAK2/STAT3 signaling in macrophages

Oncostatin M (OSM) is a secreted cytokine mainly involved in chronic inflammatory and cardiovascular diseases through binding to OSM receptor β (OSMR-β). Recent studies demonstrated that the presence of OSM contributed to the destabilization of atherosclerotic plaque. To investigate whether OSMR-β d...

Full description

Bibliographic Details
Main Authors:	Xin Zhang, Jing Li, Juan-Juan Qin, Wen-Lin Cheng, Xueyong Zhu, Fu-Han Gong, Zhigang She, Zan Huang, Hao Xia, Hongliang Li
Format:	Article
Language:	English
Published:	Elsevier 2017-05-01
Series:	Journal of Lipid Research
Subjects:	atherosclerosis inflammation Janus kinase 2/signal transducer and activator of transcription 3
Online Access:	http://www.sciencedirect.com/science/article/pii/S0022227520338256

Similar Items

Suppression of Autoimmune Arthritis by Small Molecule Inhibitors of the JAK/STAT Pathway
by: Charles J. Malemud
Published: (2010-05-01)

Targeting the JAK/STAT Signaling Pathway Using Phytocompounds for Cancer Prevention and Therapy
by: Sankhadip Bose, et al.
Published: (2020-06-01)

Activity of JAK/STAT and NF-kB in patients with axial spondyloarthritis
by: Jerzy Świerkot, et al.
Published: (2015-12-01)

“Do We Know Jack” About JAK? A Closer Look at JAK/STAT Signaling Pathway
by: Emira Bousoik, et al.
Published: (2018-07-01)

Phytochemicals Targeting JAK–STAT Pathways in Inflammatory Bowel Disease: Insights from Animal Models
by: Sun Young Moon, et al.
Published: (2021-05-01)

The Role of JAK/STAT Molecular Pathway in Vascular Remodeling Associated with Pulmonary Hypertension
by: Inés Roger, et al.
Published: (2021-05-01)

Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms
by: Paula Montero, et al.
Published: (2021-06-01)

Integrating Immunologic Signaling Networks: The JAK/STAT Pathway in Colitis and Colitis-Associated Cancer
by: Sebastian Zundler, et al.
Published: (2016-02-01)

Ceramide induces MMP-9 expression through JAK2/STAT3 pathway in airway epithelium
by: Lingling Xuan, et al.
Published: (2020-08-01)

Targeting JAK-STAT Signalling Alters PsA Synovial Fibroblast Pro-Inflammatory and Metabolic Function
by: Aisling O’Brien, et al.
Published: (2021-06-01)

<i>Drosophila</i> Jak/STAT Signaling: Regulation and Relevance in Human Cancer and Metastasis
by: Sunny Trivedi, et al.
Published: (2018-12-01)

Clinicopathologic and prognostic significance of VEGF, JAK2 and STAT3 in patients with nasopharyngeal carcinoma
by: Jin-Zhang Cheng, et al.
Published: (2018-08-01)

Ursolic acid enhances macrophage autophagy and attenuates atherogenesis[S]
by: Shuilong Leng, et al.
Published: (2016-06-01)

Fructose 1,6-diphosphate alleviates myocardial ischemia reperfusion injury in rats through JAK2/STAT3 pathway
by: Ju-Fei Wang, et al.
Published: (2018-01-01)

Isoliquiritigenin Attenuates Atherogenesis in Apolipoprotein E-Deficient Mice
by: Fen Du, et al.
Published: (2016-11-01)

Macrophage growth factors in atherogenesis
by: McMurray, Heather Forbes
Published: (1989)

Inhibitory effects of the JAK inhibitor CP690,550 on human CD4<sup>+ </sup>T lymphocyte cytokine production
by: Yamasaki Satoshi, et al.
Published: (2011-08-01)

BubR1 Insufficiency Results in Decreased Macrophage Proliferation and Attenuated Atherogenesis in Apolipoprotein E‐Deficient Mice
by: Shinichi Tanaka, et al.
Published: (2016-09-01)

CXCL1 Regulated by miR-302e Is Involved in Cell Viability and Motility of Colorectal Cancer via Inhibiting JAK-STAT Signaling Pathway
by: Biyin Chen, et al.
Published: (2021-05-01)

Angiotensin III Induces JAK2/STAT3 Leading to IL-6 Production in Rat Vascular Smooth Muscle Cells
by: Ahmed Z. Alanazi, et al.
Published: (2019-11-01)

Isolinderalactone Induces Cell Death via Mitochondrial Superoxide- and STAT3-Mediated Pathways in Human Ovarian Cancer Cells
by: Shakya Rajina, et al.
Published: (2020-10-01)

Interplay between Janus Kinase/Signal Transducer and Activator of Transcription Signaling Activated by Type I Interferons and Viral Antagonism
by: Yuchen Nan, et al.
Published: (2017-12-01)

Current perspectives on the JAK/STAT signaling pathway and its activating factors in liver fibrosis
by: PAN Jin
Published: (2013-05-01)

JAK-Inhibitors for the Treatment of Rheumatoid Arthritis: A Focus on the Present and an Outlook on the Future
by: Jacopo Angelini, et al.
Published: (2020-07-01)

Basics of Janus kinases: a review
by: Hanan R Nada, et al.
Published: (2020-01-01)

Exosomes and Atherogenesis
by: Bingbing Lin, et al.
Published: (2021-08-01)

Intestinal Na+ Loss and Volume Depletion in JAK3-Deficient Mice
by: Anja T. Umbach, et al.
Published: (2013-11-01)

Analysis of macrophage transcriptome in atherogenesis
by: M. V. Kubekina, et al.
Published: (2019-03-01)

Myeloproliferative neoplasms and the JAK/STAT signaling pathway: an overview
by: Renata Mendes de Freitas, et al.
Published: (2015-10-01)

The JAK2/STAT3/CCND2 Axis promotes colorectal Cancer stem cell persistence and radioresistance
by: So-Yeon Park, et al.
Published: (2019-09-01)

Long non-coding RNA RP11-468E2.5 curtails colorectal cancer cell proliferation and stimulates apoptosis via the JAK/STAT signaling pathway by targeting STAT5 and STAT6
by: Li Jiang, et al.
Published: (2019-11-01)

Deficiency of PTP1B Attenuates Hypothalamic Inflammation via Activation of the JAK2-STAT3 Pathway in Microglia
by: Taku Tsunekawa, et al.
Published: (2017-02-01)

Hair Growth Effect of Emulsion Extracted Brevilin A, a JAK3 Inhibitor, from <i>Centipeda minima</i>
by: Byoung Ha Kim, et al.
Published: (2020-06-01)

Caractérisation du rôle de la voie Jak/STAT dans la réponse mitogénique des récepteurs couplés aux protéines G
by: Duhamel, François
Published: (2016)

The two faces of Janus kinases and their respective STATs in mammary gland development and cancer
by: Kay-Uwe Wagner, et al.
Published: (2011-01-01)

Epigenetic Silencing of Tumor Suppressor miR-124 Directly Supports STAT3 Activation in Cutaneous T-Cell Lymphoma
by: Lidia García-Colmenero, et al.
Published: (2020-12-01)

Jak-2 mutation frequency in patients with thrombocytosis
by: Osman Yokus, et al.
Published: (2018-01-01)

High mobility group box 1 induces the activation of the Janus kinase 2 and signal transducer and activator of transcription 3 (JAK2/STAT3) signaling pathway in pancreatic acinar cells in rats, while AG490 and rapamycin inhibit their activation
by: Guoliang Wang, et al.
Published: (2016-11-01)

Janus Kinase-Signal Transducer and Activator of Transcription in target therapy of cancer
by: Lior Shoev, et al.
Published: (2019-09-01)

Janus Kinase Inhibitor Baricitinib Modulates Human Innate and Adaptive Immune System
by: Satoshi Kubo, et al.
Published: (2018-06-01)